The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors
Open accessAbstract
BACKGROUND: Pakistan carries one of the world's highest burdens of chronic hepatitis and mortality due to liver failure and hepatocellular carcinomas. However, national level estimates of the prevalence of and risk factors for hepatitis B and hepatitis C are currently not available. METHODS: We reviewed the medical and public health literature over a 13-year period (January 1994-September 2007) to estimate the prevalence of active hepatitis B and chronic hepatitis C in Pakistan, analyzing data separately for the general and high-risk populations and for each of the four provinces. We included 84 publications with 139 studies (42 studies had two or more sub-studies). RESULTS: Methodological differences in studies made it inappropriate to conduct a formal meta-analysis to determine accurate national prevalence estimates, but we estimated the likely range of prevalence in different population sub-groups. A weighted average of hepatitis B antigen prevalence in pediatric populations was 2.4% (range 1.7-5.5%) and for hepatitis C antibody was 2.1% (range 0.4-5.4%). A weighted average of hepatitis B antigen prevalence among healthy adults (blood donors and non-donors) was 2.4% (range 1.4-11.0%) and for hepatitis C antibody was 3.0% (range 0.3-31.9%). Rates in the high-risk subgroups were far higher. CONCLUSIONS: Data suggest a moderate to high prevalence of hepatitis B and hepatitis C in different areas of Pakistan. The published literature on the modes of transmission of hepatitis B and hepatitis C in Pakistan implicate contaminated needle use in medical care and drug abuse and unsafe blood and blood product transfusion as the major causal factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions
Agresti, A., & Coull, B. A. (1998) · The American Statistician · doi:10.1080/00031305.1998.10480550 · Cited by 3,223
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Schaff, Z., & Csmos, G. (1994) · Cited by 1,868
Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.
Simonsen, L., Kane, A. D., Lloyd, J. L. E., et al. (1999) · PubMed · Cited by 619
The global burden of disease attributable to contaminated injections given in health care settings
Hauri, A. M., Armstrong, G. L., & Hutin, Y. J. F. (2004) · International Journal of STD & AIDS · doi:10.1258/095646204322637182 · Cited by 458
Vandelli, C., Renzo, F., Romano, L., Tisminetzky, S., De Palma, M., Stroffolini, T., Ventura, E., & Zanetti, A. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04150.x · Cited by 310
Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates
Hutin, Y. J. F., Hauri, A. M., & Armstrong, G. L. (2003) · BMJ · doi:10.1136/bmj.327.7423.1075 · Cited by 308
LUBY, S. P., QAMRUDDIN, K., SHAH, A. A., OMAIR, A., PAHSA, O., KHAN, A. J., McCORMICK, J. B., HOODBHOUY, F., & FISHER-HOCH, S. (1997) · Epidemiology and Infection · doi:10.1017/s0950268897007899 · Cited by 219
Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan.
Khan, A. J., Luby, S. P., Fikree, F. F., Karim, A., Obaid, S., Dellawala, S., Mirza, S., Malik, T., Fisher‐Hoch, S. P., & McCormick, J. B. (2000) · Europe PMC (PubMed Central) · Cited by 206
Jafri, W., Jafri, N., Yakoob, J., Islam, M., Tirmizi, S. F. A., Jafar, T. H., Akhtar, S., Hamid, S. S., Shah, H. A., & Nizami, S. Q. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-101 · Cited by 155
Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan.
Khattak, M. F., Salamat, N., Bhatti, F. A., & Qureshi, T. Z. (2002) · PubMed · Cited by 155
Risk factors for hepatitis C virus infection in male adults in Rawalpindi–Islamabad, Pakistan
Bari, A., Akhtar, S., Rahbar, M. H., et al. (2001) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2001.00779.x · Cited by 124
(2003) · PubMed · Cited by 120
High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan.
Kuo, I. C., Hasan, S. U., Galai, N., Thomas, D. L., Zafar, T., Ahmed, M., & Strathdee, S. A. (2006) · Harm Reduction Journal · doi:10.1186/1477-7517-3-26 · Cited by 91
Alary, M., Joly, J. R., Vincelette, J., Lavoie, R., Turmel, B., & Remis, R. S. (2005) · American Journal of Public Health · doi:10.2105/ajph.2003.020388 · Cited by 88
Injection use in two districts of Pakistan: implications for disease prevention
Janjua, N. Z., Akhtar, S., & Hutin, Y. J. (2005) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzi048 · Cited by 70
Pasha, O., Luby, S. P., Khan, A. J., et al. (1999) · Epidemiology and Infection · doi:10.1017/s0950268899002770 · Cited by 67
An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan
Ahmad, N., Asgher, M., Shafique, M. W., & Qureshi, J. A. (2007) · Saudi Medical Journal · doi:10.15537/1658-3175.3816 · Cited by 61
Population beliefs about the efficacy of injections in Pakistan's Sindh province
Janjua, N. Z., Hutin, Y. J., Akhtar, S., & Ahmad, K. (2006) · Public Health · doi:10.1016/j.puhe.2006.05.004 · Cited by 58
Usman, H. R., Akhtar, S., Rahbar, M. H., Hamid, S. S., MOATTAR, T., & Luby, S. P. (2003) · Epidemiology and Infection · doi:10.1017/s0950268802008178 · Cited by 55
Prevalence of hepatitis B among Afghan refugees living in Balochistan, Pakistan
Quddus, A., Luby, S. P., Jamal, Z., & Jafar, T. (2006) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2005.04.007 · Cited by 50
Injection practices and sharp waste disposal by general practitioners of Murree, Pakistan.
Janjua, N. Z. (2003) · PubMed · Cited by 40
Intrafamilial spread of hepatitis B virus infection in Greece
Zervou, E. K., Gatselis, N., Xanthi, E., Ziciadis, K., Georgiadou, S. P., & Dalekos, G. N. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200509000-00005 · Cited by 39
Imamura, M., & Chayama, K. (2017) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.106.428 · Cited by 39
Geographical display of health information study of hepatitis C infection in Karachi, Pakistan
Mujeeb, S. A. (2000) · Public Health · doi:10.1016/s0033-3506(00)00375-9 · Cited by 34
Long-term improvement in unsafe injection practices following community intervention
Luby, S. P., Hoodbhoy, F., Jan, A., Shah, A., & Hutin, Y. J. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.03.007 · Cited by 23
HCV exposure in spouses of the index cases.
Qureshi, H. I., Arif, A., Ahmed, W., & Alam, S. E. (2007) · PubMed · Cited by 13
Self-citation
Cited by
Global burden of aflatoxin-induced hepatocellular carcinoma: A risk assessment
Liu, Y., & Wu, F. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901388 · Cited by 1,224
Epidemiology and natural history of HCV infection
Hajarizadeh, B., Grebely, J., & Dore, G. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.107 · Cited by 994
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Cooke, G. S., Andrieux-Meyer, I., Applegate, T. L., Atun, R., Burry, J. R., Cheinquer, H., Dusheiko, G., Feld, J. J., Gore, C., Griswold, M. G., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30270-x · Cited by 535
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
Sievert, W., Altraif, I., Razavi, H. A., Abdo, A., Ahmed, E. A., AlOmair, A., Amarapurkar, D., Chen, C., Dou, X., El Khayat, H., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02540.x · Cited by 534
The changing epidemiology of liver diseases in the Asia–Pacific region
Wong, M. C. S., Huang, J. L. W., George, J., Huang, J., Leung, C., Eslam, M., Chan, H. L. Y., & Ng, S. C. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0055-0 · Cited by 344
Metadata
- Authors
- Ali, S. A., Donahue, R. M. J., Qureshi, H., & Vermund, S. H.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 13
- Issue
- 1
- Pages
- 9-19
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W2018755306
- Cited by
- 361
- References
- 28
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.